Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCV3 Vaccine with PEG-IFN in HIV-1 Patients
NCT02767193Phase 1Completed
- Sponsor
- Judit Pich Martínez
- Start
- May 2016
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of autologous myeloid dendritic cell vaccine in human immunodeficiency virus infection (HIV), sponsored by Judit Pich Martínez. Started May 2016; status: completed.
02
Drugs
autologous myeloid dendritic cell vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02767193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767193.